Cedar. Co.,Ltd (JP:2435)
:2435
Want to see JP:2435 full AI Analyst Report?
Top Page
Cedar. Co.,Ltd
(2435)
Select Model
Select Model
Rating:59Neutral
Price Target:
¥218.00
▲(2.35% Upside)
Action:Downgraded
Date:05/16/26
The score is driven primarily by improving operating results and cash flow but held back by substantial balance-sheet leverage and weak technical momentum. Attractive valuation (low P/E and solid yield) provides meaningful support to the overall score.
Positive Factors
Improving cash generation
Operating and free cash flow improved materially in the latest year, showing the business is converting revenue into cash. Stronger cash generation enhances ability to fund operations, service debt and invest in facilities, supporting sustainability over the coming months.
Negative Factors
Very high leverage
Extremely high debt relative to a small equity base materially restricts financial flexibility. Elevated leverage increases refinancing and interest-rate risk, and leaves limited capacity to absorb earnings volatility or fund capex without raising costly capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving cash generation
Operating and free cash flow improved materially in the latest year, showing the business is converting revenue into cash. Stronger cash generation enhances ability to fund operations, service debt and invest in facilities, supporting sustainability over the coming months.
Read all positive factors
Cedar. Co.,Ltd (2435) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥2.35B
Dividend Yield4.76%
Average Volume (3M)141.26K
Price to Earnings (P/E)4.7
Beta (1Y)0.65
Revenue Growth1.88%
EPS Growth17.79%
CountryJP
Employees1,332
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)41.88
Shares Outstanding11,476,000
10 Day Avg. Volume352,360
30 Day Avg. Volume141,263
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.25
Price to Sales (P/S)0.14
P/FCF Ratio2.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cedar. Co.,Ltd Business Overview & Revenue Model
Company Description
CEDAR.Co.,Ltd. provides nursing care and rehabilitation services in Japan. It offers day care, resident life care, home-visit nursing care, home help, home care support, group home, and short-term residency care services. CEDAR.Co.,Ltd. was incorp...
How the Company Makes Money
null...
Cedar. Co.,Ltd Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
28
Negative
Cash Flow
55
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.89B | 18.16B | 17.83B | 17.30B | 16.44B | 15.75B |
| Gross Profit | 2.19B | 2.15B | 2.34B | 2.21B | 1.59B | 1.55B |
| EBITDA | 1.72B | 1.46B | 1.66B | 1.45B | 831.00M | 728.00M |
| Net Income | 374.00M | 524.00M | 444.00M | 203.00M | -276.00M | -319.00M |
Balance Sheet | ||||||
| Total Assets | 20.42B | 19.72B | 20.00B | 20.33B | 20.25B | 20.46B |
| Cash, Cash Equivalents and Short-Term Investments | 1.80B | 1.77B | 1.48B | 1.64B | 1.03B | 796.00M |
| Total Debt | 14.26B | 13.80B | 14.47B | 15.22B | 15.63B | 15.84B |
| Total Liabilities | 18.93B | 17.76B | 18.50B | 19.23B | 19.35B | 19.30B |
| Stockholders Equity | 1.47B | 1.96B | 1.49B | 1.08B | 891.00M | 1.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 823.00M | 295.00M | 995.00M | 394.00M | -984.00M |
| Operating Cash Flow | 0.00 | 1.25B | 777.00M | 1.47B | 797.00M | 513.00M |
| Investing Cash Flow | 0.00 | -402.00M | -142.00M | -446.00M | -358.00M | -1.47B |
| Financing Cash Flow | 0.00 | -582.00M | -791.00M | -418.00M | -207.00M | 928.00M |
Cedar. Co.,Ltd Technical Analysis
Neutral
213.00
Price Trends
214.71
Positive
210.19
Positive
211.58
Positive
Market Momentum
0.79
Positive
49.09
Neutral
9.52
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2435, the sentiment is Neutral. The current price of 213 is below the 20-day moving average (MA) of 218.20, below the 50-day MA of 214.71, and above the 200-day MA of 211.58, indicating a neutral trend. The MACD of 0.79 indicates Positive momentum. The RSI at 49.09 is Neutral, neither overbought nor oversold. The STOCH value of 9.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:2435.
Cedar. Co.,Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥3.01B | 4.69 | ― | 2.82% | 5.16% | 19.94% | |
59 Neutral | ¥2.35B | 4.69 | ― | 4.76% | 1.88% | 17.79% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥5.56B | 23.20 | ― | 4.07% | 4.75% | 20.56% | |
51 Neutral | ¥2.78B | 24.82 | ― | 2.56% | -6.54% | -69.23% | |
49 Neutral | ¥1.26B | 43.32 | ― | ― | 9.08% | 30.71% |
* Healthcare Sector Average
JP:2435
Cedar. Co.,Ltd
209.00
-27.44
-11.61%
JP:2373
Care Twentyone Corporation
413.00
28.02
7.28%
JP:2425
Care Service Co., Ltd.
733.00
-38.83
-5.03%
JP:7362
Terminalcare Support Institute, Inc.
822.00
42.00
5.38%
JP:9220
FB CARE SERVICE CO.,LTD.
1,236.00
278.87
29.14%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.